14T143: Ehlers Danlos Syndrome and Joint Hypermobility Syndrome: A Not-So Benign Disorder?

Tuesday, November 14, 2023

2:00 PM - 3:00 PM PT

Location: Room 1A-B

CE: 1

Speaker(s)

KF

Khosro Farhad, MD

Mass General Brigham
Boston, MA, United States

Disclosure(s): No financial relationships with ineligible companies to disclose
JM

Jeff Milunsky, MD

Center for Human Genetics
Cambridge, MA, United States

Disclosure(s): No financial relationships with ineligible companies to disclose
DM

Deeba Minhas, MD

University of Michigan
Bloomfield Hills, MI, United States

Disclosure(s): No financial relationships with ineligible companies to disclose

This session will review the approach to diagnosing joint hypermobility syndrome and Ehlers Danlos Syndrome with a focus on the role of genetics. It will also discuss complications of joint hypermobility syndrome and Ehlers Danlos Syndrome, including autonomic dysfunction and chronic pain syndromes.

Learning Objectives:

Review the diagnostic approach to joint hypermobility syndrome and Ehlers Danlos Syndrome and understand the role of the geneticist.
Recognize autonomic dysfunction in joint hypermobility syndrome and Ehlers Danlos Syndrome
Understand pain syndromes in joint hypermobility syndrome and Ehlers Danlos Syndrome and improve therapeutic approaches

Presentations:

2:00 PM - 2:15 PM PT

Clinical Evaluation of Ehlers Danlos Syndrome and Joint Hypermobility Syndrome and the Role of Genetics
Speaker: Jeff Milunsky, MD – Center for Human Genetics
2:15 PM - 2:30 PM PT

Autonomic Neuropathy and Dysautonomia in Ehlers Danlos Syndrome and Joint Hypermobility Syndrome
Speaker: Khosro Farhad, MD – Mass General Brigham
2:30 PM - 2:45 PM PT

Chronic Pain Syndromes in Ehlers Danlos Syndrome and Joint Hypermobility Syndrome
Speaker: Deeba Minhas, MD – University of Michigan
2:45 PM - 3:00 PM PT

Q&A